Literature DB >> 35070428

Long noncoding RNA NEAT1 changes exosome secretion and microRNA expression carried by exosomes in hepatocellular carcinoma cells.

Shengning Zhang1, Yuanyi Mang1, Li Li1, Jianghua Ran1, Yingpeng Zhao1, Laibang Li1, Yang Gao1, Wang Li1, Guoyu Chen1, Jun Ma1.   

Abstract

BACKGROUND: This study aimed to investigate the roles and functions of nuclear-enriched abundant transcript 1 (NEAT1) in exosome secretion and exosomal microRNA (miRNA) changes in hepatocellular carcinoma (HCC) cells.
METHODS: HepG2 and HuH-7 cells were divided into two groups: Lv-control (which were infected with lentivirus without NEAT1 expression) and Lv-NEAT1 (which were infected with lentivirus with NEAT1 overexpression). Each group was used to study cell function (proliferation, invasion, and apoptosis) and exosome secretion by nanoparticle tracking analysis (NTA), electron microscopy, and nanoflow cytometry (nanoFCM). Different levels of messenger RNA (mRNA), miRNA, and exosomal miRNA were detected by RNA sequencing. Next, potential target RNAs were verified by reverse transcription polymerase chain reaction (RT-PCR). Changed exosomal miRNAs were found and miRNA mimics were used to study cell function in NEAT1-overexpression and NEAT1-knockdown HCC cells.
RESULTS: The data showed that NEAT1-overexpression promoted exosome secretion. The overexpression of NEAT1 altered global genes, including exosome-related genes. Compared with the control group, we observed that several miRNAs changed in the exosomes secreted by NEAT1-overexpressing cells. Our study found that these changed exosomal miRNAs played a suppressor role in HCC. Transfection of miR-634, miR-638, and miR-3960 reversed the enhanced invasion and proliferation in HCC cells with a high level of NEAT1 expression.
CONCLUSIONS: These results suggested that NEAT1 regulates exosome-related genes, which might be associated with increasing exosome secretion by NEAT1-overexpressing cells. Furthermore, NEAT1 promotes cell invasion and proliferation via downregulation of miR-634, miR-638, and miR-3960 in exosomes. This study may provide potential targets for exosome-mediated miRNA transfer in HCCs with a high level of NEAT1 expression therapy. 2021 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  Long noncoding RNA (lncRNA); exosome; hepatocellular carcinoma (HCC); microRNA (miRNA); nuclear-enriched abundant transcript 1 (NEAT1)

Year:  2021        PMID: 35070428      PMCID: PMC8748037          DOI: 10.21037/jgo-21-729

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  50 in total

Review 1.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

2.  NEAT1 upregulates TGF-β1 to induce hepatocellular carcinoma progression by sponging hsa-mir-139-5p.

Authors:  Jianfei Tu; Zhongwei Zhao; Min Xu; Xiaojie Lu; Liu Chang; Jiansong Ji
Journal:  J Cell Physiol       Date:  2018-05-24       Impact factor: 6.384

3.  Loss of miR-638 promotes invasion and epithelial-mesenchymal transition by targeting SOX2 in hepatocellular carcinoma.

Authors:  Yu Zhang; Di Zhang; Jiong Jiang; Lei Dong
Journal:  Oncol Rep       Date:  2016-11-23       Impact factor: 3.906

Review 4.  Exosomes in inflammation and role as biomarkers.

Authors:  Lara Console; Mariafrancesca Scalise; Cesare Indiveri
Journal:  Clin Chim Acta       Date:  2018-11-09       Impact factor: 3.786

5.  The long noncoding RNA NEAT1 contributes to hepatocellular carcinoma development by sponging miR-485 and enhancing the expression of the STAT3.

Authors:  Xu-Nan Zhang; Jun Zhou; Xiao-Jie Lu
Journal:  J Cell Physiol       Date:  2018-04-16       Impact factor: 6.384

Review 6.  Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets.

Authors:  Marcel Klingenberg; Akiko Matsuda; Sven Diederichs; Tushar Patel
Journal:  J Hepatol       Date:  2017-04-22       Impact factor: 25.083

Review 7.  Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.

Authors:  Amit G Singal; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-15       Impact factor: 11.382

8.  Hepatocellular carcinoma in a large medical center of China over a 10-year period: evolving therapeutic option and improving survival.

Authors:  Qianqian Zhu; Na Li; Xiaoyan Zeng; Qunying Han; Fang Li; Cuiling Yang; Yi Lv; Zhihua Zhou; Zhengwen Liu
Journal:  Oncotarget       Date:  2015-02-28

9.  Insulin-like growth factor-1 prevents miR-122 production in neighbouring cells to curtail its intercellular transfer to ensure proliferation of human hepatoma cells.

Authors:  Sudarshana Basu; Suvendra N Bhattacharyya
Journal:  Nucleic Acids Res       Date:  2014-05-09       Impact factor: 16.971

10.  Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1.

Authors:  Jing Yang; Bo Li; Shuo Zhao; Hongyu Du; Yaming Du
Journal:  Onco Targets Ther       Date:  2020-07-07       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.